New ESC guidelines for ACS favour ticagrelor over clopidogrel

New ESC guidelines recommend ticagrelor (Brilinta/Brilique, AstraZeneca) for all non-ST elevation ACS patients at moderate to high risk of ischaemic events, including those on clopidogrel (Plavix, Sanofi) who can be switched to ticagrelor.  Prasugrel (Effient, Lilly) is recommended for P2Y12- … Continue reading